Donegal Clinical and Research Academy, Breast Centre North West, Letterkenny Hospital, Donegal, Ireland.
Introduction: Rapid and appropriate family risk assessment and triage of patients are essential for patients presenting to a symptomatic breast unit and international criteria for review are well established. Family History Risk Assessment Software (FaHRAS) is a computerized program, involving different modalities of risk assessment, which is available but has not been widely assessed. Aims: This study evaluated the FaHRAS software scoring of family history risk. Its analysis was compared to multi-tool family history risk assessment models in a cohort of 353 patients on a historic family history waiting list. Methods: A recent published pilot study assessed and categorized family history risk in 353 patients on a historic family history waiting list, according to international guidelines including NICE criteria, Gail and IBIS risk estimates. The current study involved a reassessment of all 353 patients using the FaHRAS software program to determine its accuracy and ease of use. Patient demographics and time required to perform the analysis were documented. Results: FaHRAS identified 73 (20.7%) patients had an IBIS family history score of 17% or greater and 89 (25.2%) patients met the NICE guidelines criteria for management beyond primary care. In the previous study, this was 79 (22.4%) and 112 (31.7%) respectively. Using the largest denominator (NICE guidelines), 264/353 (74.8%) patients could be discharged to primary care using FaHRAS. Using this largest denominator, FaHRAS also identified a total of 28 (7.9%) patients requiring referral to tertiary care while the previous study identified 3 (0.8%). Conclusion: This is one of the first studies to validate FaHRAS, which is accurate and easy to use. FaHRAS system can enable clinicians to become more efficient gatekeepers to genetic services.
Gorman, Á. , Sugrue, M. , Ahmed, Z. and Johnston, A. (2014) An Evaluation of FaHRAS Computer Programmes’ Utility in Family History Triage of Breast Cancer. Advances in Breast Cancer Research, 3, 17-21. doi: 10.4236/abcr.2014.32004.
[1] Linsell, L., et al. (2009) A Randomised Controlled Trial of an Intervention to Promote Early Presentation of Breast Cancer in Older Women: Effect on Breast Cancer Awareness. British Journal of Cancer, 101, 40-S48. http://dx.doi.org/10.1038/sj.bjc.6605389 [2] Watson, E., Austoker, J. and Lucassen, A. (2001) A Study of GP Referrals to a Family Cancer Clinic for Breast/Ovarian Cancer. Family Practice, 18, 131-134. http://dx.doi.org/10.1093/fampra/18.2.131 [3] Welch, H.G., Schwartz, L.M. and Woloshin, S. (2011) Overdiagnosed: Making People Sick in the Pursuit of Health. Beacon Press, Boston. [4] Collaborative Group on Hormonal Factors in Breast Cancer (2001) Familial Breast Cancer: Collaborative Reanalysis of Individual Data from 52 Epidemiological Studies including 58209 Women with Breast Cancer and 101 986 Women without the Disease. Lancet, 358, 1389-1399.
http://dx.doi.org/10.1016/S0140-6736(01)06524-2 [5] Rose, P., et al. (2001) Referral of Patients with a Family History of Breast/Ovarian Cancer—GPs’ Knowledge and Expectations. Family Practice, 18, 487-490. http://dx.doi.org/10.1093/fampra/18.5. 487 [6] Carter, R.F. (2001) BRCA1, BRCA2 and Breast Cancer: A Concise Clinical Review. Clinical & Investigative Medicine, 243, 147-157. [7] Lakhani, N.S., Weir, J., Alford, A., Kai, J. and Barwell, J.G. (2009-2011)Could Triaging Family History of Cancer during Palliative Care Enable Earlier Genetic Counselling Interventions for Families at High Risk? Tipping Points Project (2009-2011). [8] Maurice, A., et al. (2006) Screening Younger Women with a Family History of Breast Cancer—Does Early Detection Improve Outcome? European Journal of Cancer, 42, 1385-1390.
http://dx.doi.org/10.1016/j.ejca.2006.01.055 [9] National Institute for Health and Care Excellence (2013) Familial Breast Cancer: Classification and Care of People at Risk of Familial Breast Cancer and Management of Breast Cancer and Related Risks in People with a Family History of Breast Cancer. Update of Clinical Guideline 14 and 41. (Clinical Guideline 164.). http://guidance.nice.org.uk/CG164 [10] Guerra, C.E., Sherman, M. and Armstrong, K. (2009) Diffusion of Breast Cancer Risk Assessment in Primary Care. The Journal of the American Board of Family Medicine, 22, 272-279.
http://dx.doi.org/10.3122/jabfm.2009.03.080153 [11] Ahmed, Z., Shields, G., Momin, M., Curran, S. and Sugrue, M. (2010) Breast Cancer Family History Risk Assessment, Fact or Fantasy? Irish Journal of Medical Sciences, 179, S331-S373. [12] Thomas, J., Sugrue, M., Curran, S., Furey, M. and Sugrue, R. (2013) Are Family Doctors Compliant with Breast Family History Guidelines? Advances in Breast Cancer Research, 2, 149-153.
http://dx.doi.org/10.4236/abcr.2013.24024 [13] National Cancer Control Programme. http://www.hse.ie/eng/services/list/5/nccp/ [14] Gail, M., et al. (1989) Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined Annually. Journal of the National Cancer Institute, 81, 1879-1886. http://dx.doi.org/10.1093/jnci/81.24.1879 [15] IBIS Software Tyrer-Cuzick Computerised Model V6 (2008) http://www.ems-trials.org/riskevaluator/ [16] Antoniou, A.C., et al. (2006) BRCA1 and BRCA2 Mutation Predictions Using the BOADICEA and BRCAPRO Models and Penetrance Estimation in High-Risk French-Canadian Families. Breast Cancer Research, 8, R3. http://dx.doi.org/10.1186/bcr1365 [17] Amir, E.O., Freedman, C., Evans, D.G. and Seruga, B. (2010) Assessing Women at High Risk of Breast Cancer: A Review of Risk Assessment Models. Journal of the National Cancer Institute, 102, 680-691. http://dx.doi.org/10.1093/jnci/djq088 [18] Emery, J.R., et al. (2000) Computer Support for Interpreting Family Histories of Breast and Ovarian Cancer in Primary Care: Comparative Study with Simulated Cases. British Medical Journal, 321, 28-32. http://dx.doi.org/10.1136/bmj.321.7252.28 [19] Parmigiani, G.S., et al. (2007) Validity of Models for Predicting BRCA1 and BRCA2 Mutations. Annals of Internal Medicine, 147, 441-450. http://dx.doi.org/10.7326/0003-4819-147-7-200710020-00002 [20] Antoniou, A.P., Pharoah, P., Smith, P. and Easton, D.F. (2004) The BOADICEA Model of Genetic Susceptibility to Breast and Ovarian Cancer. British Journal of Cancer, 91, 1580-1590.